Director at Modular Medical (MODD) receives 250 fully vested options

Rhea-AI Filing Summary

Modular Medical, Inc. director Ellen O'Connor Vos received a grant of options to purchase 250 shares of common stock at an exercise price of $4.88 per share. The options were granted under the Outside Director Compensation Plan, were fully vested and exercisable on the grant date, and expire on June 30, 2036.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Vos Ellen O'Connor

Role null

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock	250	$0.00	--

Holdings After Transaction: Option to purchase common stock — 250 shares (Direct, null)

Footnotes (1)

1. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Option grant size: 250 options Exercise price: $4.88 per share Expiration date: June 30, 2036 +2 more

5 metrics

Option grant size 250 options Options to purchase common stock granted June 30, 2026

Exercise price $4.88 per share Exercise price of the options to buy common stock

Expiration date June 30, 2036 Option grant expiration for director’s award

Beneficial ownership of this option class 250 derivative securities Total options of this class following the transaction

Transaction code A Grant, award, or other acquisition of derivative security

Key Terms

Outside Director Compensation Plan, beneficial ownership, derivative security

3 terms

Outside Director Compensation Plan financial

"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan"

beneficial ownership financial

"column 9 reports only total beneficial ownership of the "class" of derivative security"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

derivative security financial

"total beneficial ownership of the "class" of derivative security reported in Column 1"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:34 PM Accepted by SEC EDGAR 07/02/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vos Ellen O'Connor

(Last) (First) (Middle)

C/O MODULAR MEDICAL, INC.

10740 THORNMINT ROAD

(Street)

SAN DIEGO CALIFORNIA 92127

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock(1)	$4.88	06/30/2026		A		250		06/30/2026	06/30/2036	Common Stock	250	(1)	250(2)	D

Explanation of Responses:

1. The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	/s/ James Sullivan, attorney-in-fact for Ellen O'Connor Vos	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Modular Medical (MODD) report for Ellen O'Connor Vos?

Modular Medical reported that director Ellen O'Connor Vos received a grant of options to purchase 250 shares of common stock. These options were awarded under the company’s Outside Director Compensation Plan as part of her director compensation.

What are the key terms of Ellen O'Connor Vos’s stock options at Modular Medical (MODD)?

The grant covers options to buy 250 shares of Modular Medical common stock at an exercise price of $4.88 per share. The options were fully vested and exercisable on the grant date and have a long-term expiration in 2036.

When do Ellen O'Connor Vos’s Modular Medical (MODD) options vest and expire?

The options granted to Ellen O'Connor Vos were fully vested and exercisable on the June 30, 2026 grant date. They carry an expiration date of June 30, 2036, giving a 10-year window during which the options may be exercised.

How many shares does the new option grant at Modular Medical (MODD) cover?

The new award gives Ellen O'Connor Vos options over 250 shares of Modular Medical common stock. Following this grant, her reported beneficial ownership for this option class is 250 derivative securities tied to the same underlying common stock.

Under what plan were Ellen O'Connor Vos’s Modular Medical (MODD) options granted?

The option grant to Ellen O'Connor Vos was made under Modular Medical’s Outside Director Compensation Plan. This plan governs how non-employee directors are compensated in equity, including terms such as vesting, exercise price, and overall grant structure.